Shaping the future of animal health
Virbac group
Innovation contact
Virbac is seeking actively collaborations on state of the art technologies, new actives that can be the basis for innovation products:
Business development contact
Virbac is seeking for new commercial opportunities and business:

Research and Development

Research into new veterinary products and their development are at the heart of Virbac's innovation missions. Every day throughout the world, three hundred men and women devote all their energy to fulfilling customers' needs and creating the products of tomorrow. In France, where the company has its largest centre, R&D focuses on two main aspects. Firstly, biological R&D which develops biological products (vaccines, etc.) and, secondly, pharmaceutical R&D which develops a wide range of pharmacological therapeutic products (anti-infective, internal and external parasiticides, anti-inflammatories, etc.) intended for all animal species.
Worldwide, the skills of each R&D teams are focused on specific projects based on their know-how, resources and to a certain extent closeness to regional breedings.
Depending on its size, each centre has multi-disciplinary teams and the latest equipment devoted to the studies needed to demonstrate the quality, safety and efficacy of the company's products. The regulations, which are ever-present in this sphere of activity, impose strict rules of operation concerning good manufacturing, laboratory and clinical practices and drug monitoring.
The special feature of R&D at Virbac is the integration of regulatory expertise and thus the responsibility for all the activities involved in setting up and drafting authorisation dossiers in partnership with the Regulatory Affairs department. R&D is of course in charge of technical and scientific exchanges with the veterinary medicine agencies.


Share on Google Share on Facebook Print current page